Evidence map›Paper›PMID 39627230›Full record

ArticleNature communications2024

Maximizing light-to-heat conversion of Ti

Hwansoo Shin, Woojae Jeong, Tae Hee Han

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. TiACS omega · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. TiACS applied materials & interfaces · 2026
    Article
  7. Article
  8. Review
  9. Orientation Engineering of MXene Flakes.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. 3D-MOF-Lattice Inspired Programmable Metamaterials Based on Reconfigurable Polyhedral Origami.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hwansoo ShinDepartment of Organic and Nano Engineering, Hanyang University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-4291-5941
Woojae JeongDepartment of Organic and Nano Engineering, Hanyang University, Seoul, Republic of Korea.
Tae Hee HanDepartment of Organic and Nano Engineering, Hanyang University, Seoul, Republic of Korea. than@hanyang.ac.kr.ORCID http://orcid.org/0000-0001-5950-7103

Funding

National Research Foundation of Korea (NRF) 2022M3H4A1A03085360National Research Foundation of Korea (NRF) RS-2024-00408845
6 · The paper itself

Abstract

MXene, a promising photothermal nanomaterial, faces challenges due to densely stacked nanosheets with high refractive index (RI). To maximize photothermal performance, MXene metamaterials (m-MXenes) are developed with a superlattice with alternating MXene and organic layers, reducing RI and inducing multiple light reflections. This approach increases light absorption, inducing 90% photothermal conversion efficiency. The m-MXene is coated onto liquid crystal elastomer (LCE) fibers, as actuating platforms via a dip-coating (m-MXene/aLCE fiber), exhibiting excellent light-driven actuating owing to the synergetic effect of the patterned m-MXene laysers by structural deformation. The m-MXene/aLCE fibers lift ~6,900 times their weight and exhibit a work density 6 times higher than that of human skeletal muscle. It is applied to artificial muscles, grippers, and a bistable structure (a shooting device, and switchable gripper). Our study offers an effective strategy to enhance light absorption in 2D nanomaterials and contributes to advancements in photothermal technologies in various fields.

Identifiers

PMID39627230
PMCPMC11614877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.